#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    IPEX syndrome Hormone-dependent prostate cancer Arrhythmogenic right ventricular dysplasia Neoplasm Oesophageal adenocarcinoma Follicular lymphoma Allogenic stem cell transplantation Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Paraneoplastic neurological syndrome B-cell lymphoma refractory Dermatitis Meningitis meningococcal Juvenile idiopathic arthritis Cardiac arrest Small intestine adenocarcinoma More trials…

    Learn about Rare Diseases

    Hyperoxaluria – Treatment Pulmonary fibrosis Hereditary motor and sensory neuropathy – Treatment Langerhans’ cell histiocytosis – Diagnostics Angiosarcoma non-metastatic Encephalitis autoimmune – Diagnostics Primary immunodeficiency syndrome – Trials in Disease Mucous membrane pemphigoid – Basic Information Leukoencephalopathy – Trials in Disease Alagille syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Efavirenz Chloroprocaine Hydrochloride AZD0022 Albaconazole Azd0901 Plerixafor LY3372993 Sodium Lactate Solution Cevostamab Wt1 Lamp Mrna Dc RO7288817 YOHIMBINE HYDROCHLORIDE Ferumoxytol Azd9550 Delandistrogene Moxeparvovec Depemokimab Fedratinib Vamorolone Nicotine Risperidone More therapies…

    Learn about Your Condition

    Myelodysplastic syndrome Renal impairment Menopause Neurogenic bladder Breast cancer male Leukaemia Lymphoma Adenomyosis Rabies Abdominal wall pain Depression Nocturia Marginal zone lymphoma Rectal cancer stage III Oesophageal achalasia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire Amiens Picardie

Centre Hospitalier Universitaire Amiens Picardie

1 Place Victor Pauchet, Amiens, 80080, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Idarubicin
    • Cytarabine
    • Daunorubicin
    France

  • Study on the Effects and Safety of Alpelisib for Children and Adults with Megalencephaly-Capillary Malformation Polymicrogyria Syndrome

    Recruiting

    2 1 1
    Investigated Diseases:
    • PIK3CA related overgrowth spectrum
    Investigated Drugs:
    • Alpelisib
    France

  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Heparin Calcium
    • Fondaparinux Sodium
    • Heparin Sodium
    France

  • Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    • Pembrolizumab
    Belgium Czechia France Germany Greece Ireland +4

  • Study on FOLFOX Chemotherapy for Treating Advanced Colon Cancer in Patients Aged 70 and Older

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Adenocarcinoma of colon
    Investigated Drugs:
    • Fluorouracil
    • Folinic Acid
    • Oxaliplatin
    France

  • Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Iberdomide
    • Apixaban
    • Rivaroxaban
    Austria Belgium Czechia Denmark Finland France +10

  • Study of Glofitamab with Rituximab or Obinutuzumab and Drug Combination for Untreated Richter’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Glofitamab
    France

  • Rituximab versus azathioprine for remission maintenance in patients with primary angiitis of the central nervous system – randomized controlled trial

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Azathioprine
    • Rituximab
    France

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain

  • Study on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Obefazimod
    Belgium France Germany Italy Poland Spain
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!